New Approaches for LNP Design and Microfluidic Manufacturing for Vaccines and CAR T Cell Therapy

RNA can be designed to silence, express and edit specific genes, providing a flexible approach to treating disease. However, due to its degradation and low cellular uptake, it requires lipid nanoparticle (LNP) delivery systems to target tissues and cells for vaccines and ex vivo cell therapies. In this webinar presented by Dr. Samuel Clarke, Director of Reagents at Precision NanoSystems, learn new approaches for RNA delivery for the development of vaccines and CAR T cell therapy.